Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lignum Santali Albi is the pharmaceutical name for the dried heartwood of *Santalum album* L. (Family Santalaceae), commonly known as White Sandalwood. It is a significant botanical drug in Traditional Chinese Medicine (TCM) and Ayurveda, primarily valued for its volatile oil content, which is rich in sesquiterpene alcohols such as alpha-santalol and beta-santalol. Pharmacologically, it is used to treat conditions related to Qi stagnation and blood stasis, particularly in the cardiovascular and gastrointestinal systems. It is a key component in several traditional formulations, including Kuanxiong (KX) Aerosol and Guanxin Suhe Wan (GSW), which are indicated for the treatment of angina pectoris and coronary heart disease. Research indicates that its active constituents possess anti-inflammatory, antioxidant, and vasorelaxant properties, and it is also used for its sedative and aromatic qualities in various therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on santalum album heartwood.